Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             44 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A case of adult Pompe disease presenting with severe fatigue and selective involvement of type 1 muscle fibers van den Berg, Linda E.M.
 2011
 21 Supplement 1 p. 232-234
3 p.
 artikel
2 A new window on neurocognitive dysfunction in the childhood form of myotonic dystrophy type 1 (DM1) Angeard, Nathalie
 2011
 21 Supplement 1 p. 468-476
9 p.
 artikel
3 Disease impact in chronic progressive external ophthalmoplegia: More than meets the eye Smits, Bart W.
 2011
 21 Supplement 1 p. 272-278
7 p.
 artikel
4 Duchenne muscular dystrophy: Survival by cardio-respiratory interventions Ishikawa, Yuka
 2011
 21 Supplement 1 p. 47-51
5 p.
 artikel
5 Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1 Perbellini, Riccardo
 2011
 21 Supplement 1 p. 81-88
8 p.
 artikel
6 Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: A comprehensive review of the clinical, histological and pathological features Cowling, Belinda S.
 2011
 21 Supplement 1 p. 237-251
15 p.
 artikel
7 Hereditary peripheral neuropathies of childhood: An overview for clinicians Wilmshurst, Jo M.
 2011
 21 Supplement 1 p. 763-775
13 p.
 artikel
8 Individual patient (n =1) “trials” in Duchenne dystrophy Catlin, Nick
 2011
 21 Supplement 1 p. 525-526
2 p.
 artikel
9 Infantile-onset spinal muscular atrophy with respiratory distress-1 diagnosed in a 20-year-old man Pierson, Tyler Mark
 2011
 21 Supplement 1 p. 353-355
3 p.
 artikel
10 Intragenic rearrangements in LARGE and POMGNT1 genes in severe dystroglycanopathies Vuillaumier-Barrot, S.
 2011
 21 Supplement 1 p. 782-790
9 p.
 artikel
11 Myonuclear breakdown in sporadic inclusion body myositis is accompanied by DNA double strand breaks Nishii, Makoto
 2011
 21 Supplement 1 p. 345-352
8 p.
 artikel
12 O07 Neuregulin-1 is required for axoglial signalling following peripheral nerve injury to ensure normal re-myelination and functional recovery Flicker, F.R.
 2011
 21 Supplement 1 p. S3-
1 p.
 artikel
13 O13 Skeletal muscle MRI-determined fat fraction and myometric strength in inclusion body myositis and Charcot-Marie-Tooth disease Type 1A Sinclair, C.D.J.
 2011
 21 Supplement 1 p. S5-
1 p.
 artikel
14 P40 A family with a TRPV4 related neuropathy displays marked phenotypic variability ranging from profound neuromuscular disability to non-penetrance Aharoni, S.
 2011
 21 Supplement 1 p. S17-
1 p.
 artikel
15 P74 An MRI study of the effects of metoprolol on in vivo cardiac calcium homeostasis Blain, A.
 2011
 21 Supplement 1 p. S28-
1 p.
 artikel
16 P5.69 Bulbofacial myopathy with anti-amphiphysin 2 (BIN 1) antibodies – A new paraneoplastic neurological syndrome? Reimann, J.
 2011
 21 Supplement 1 p. 745-
1 p.
 artikel
17 P5.12 Congenital myotonia caused by mutations in the chloride channel ClC-1 in the South Moravian Region of Czech Republic Vohanka, S.
 2011
 21 Supplement 1 p. 727-
1 p.
 artikel
18 P5.28 Culture supernatants from HTLV-1 infected T cells modify adhesion molecule-related gene signature in differentiated human muscle Castro, F.M.M.
 2011
 21 Supplement 1 p. 732-
1 p.
 artikel
19 P3.14 Drug treatment in spinal muscular atrophy types 1, 2 and 3: An update of the systematic Cochrane review Wadman, R.I.
 2011
 21 Supplement 1 p. 686-
1 p.
 artikel
20 P21 ErbB3 binding protein-1 (Ebp1) contributes to the control of proliferation and differentiation in adult muscle satellite cells Figeac, N.
 2011
 21 Supplement 1 p. S12-
1 p.
 artikel
21 P5.27 Evidence for the Implication of Th-1 and Treg cells but not Th-17 in sporadic Inclusion Body Myositis Allenbach, Y.
 2011
 21 Supplement 1 p. 732-
1 p.
 artikel
22 P5.3 Fatigue and daytime sleepiness scale in myotonic dystrophy type 1 Hermans, M.C.E.
 2011
 21 Supplement 1 p. 724-
1 p.
 artikel
23 P12 Generation of a new mouse model for therapeutic testing in the dystroglycanopathies Whitmore, C.
 2011
 21 Supplement 1 p. S10-
1 p.
 artikel
24 P43 Genetic modifying factors for the common form of CMT1A due to the chromosome 17 duplication and other causes of CMT1 in non-CMT1A patients Pandraud, A.
 2011
 21 Supplement 1 p. S18-
1 p.
 artikel
25 P5.78 IGF-1 induces myostatin expression through differential activation of the signaling pathways PI3K/Akt, Calcineurin/NFAT, ERK/CREB, CamK-MEF, Smad2/3 during myoblast proliferation and differentiation Flores, S.
 2011
 21 Supplement 1 p. 747-
1 p.
 artikel
26 Plastin 3 expression in discordant spinal muscular atrophy (SMA) siblings Bernal, Sara
 2011
 21 Supplement 1 p. 413-419
7 p.
 artikel
27 P57 Mitochondrial DNA mutations in satellite cells Spendiff, S.
 2011
 21 Supplement 1 p. S22-
1 p.
 artikel
28 P4.42 Muscle protein synthesis in patients with Dystrophia Myotonica type 1 Ørngreen, M.C.
 2011
 21 Supplement 1 p. 717-
1 p.
 artikel
29 P09 Patient-specific viral rescue therapies for Duchenne muscular dystrophy Ritso, M.
 2011
 21 Supplement 1 p. S9-
1 p.
 artikel
30 P26 Pyridostigmine-responsive limb-girdle congenital myasthenic syndrome with frequent tubular aggregates Müller, J.
 2011
 21 Supplement 1 p. S13-S14
2 p.
 artikel
31 P5.45 Recurrent rhabdomyolysis caused by LPIN 1 gene mutation in a patient affected by Charcot–Marie–Tooth 1A Nascimento, A.
 2011
 21 Supplement 1 p. 737-738
2 p.
 artikel
32 P1.13 Respiratory pattern during water swallowing in patients with Duchenne muscular dystrophy and myotonic dystrophy type 1 Nozaki, S.
 2011
 21 Supplement 1 p. 645-
1 p.
 artikel
33 P3.4 Spinal muscular atrophy with respiratory distress type 1 (SMARD-1). A clinico-pathological follow-up Millan-Tejado, B. San
 2011
 21 Supplement 1 p. 683-
1 p.
 artikel
34 P4.43 Therapeutic effect of metformin against insulin resistance in myotonic dystrophy type 1 Takada, H.
 2011
 21 Supplement 1 p. 717-
1 p.
 artikel
35 P5.66 The role of Neuraminidase 1 on skeletal muscle regeneration Neves, J.C.
 2011
 21 Supplement 1 p. 744-
1 p.
 artikel
36 Recombinant expression of the AChR-alpha1 subunit for the detection of conformation-dependent epitopes in Myasthenia Gravis Ching, Kathryn H.
 2011
 21 Supplement 1 p. 204-213
10 p.
 artikel
37 Report on the Second Endocrine Aspects of Duchenne Muscular Dystrophy Conference December 1–2, 2010, Baltimore, Maryland, USA Leung, D.G.
 2011
 21 Supplement 1 p. 594-601
8 p.
 artikel
38 Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD) Nadarajah, V.D.
 2011
 21 Supplement 1 p. 569-578
10 p.
 artikel
39 The risks of therapeutic misconception and individual patient (n =1) “trials” in rare diseases such as Duchenne dystrophy Aartsma-Rus, Annemieke
 2011
 21 Supplement 1 p. 13-15
3 p.
 artikel
40 The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice Messina, Sonia
 2011
 21 Supplement 1 p. 579-589
11 p.
 artikel
41 Two cases of oculopharyngeal muscular dystrophy (OPMD) with the rare PABPN1 c.35G>C; p.Gly12Ala point mutation Robinson, David O.
 2011
 21 Supplement 1 p. 809-811
3 p.
 artikel
42 White matter abnormalities and neurocognitive correlates in children and adolescents with myotonic dystrophy type 1: A diffusion tensor imaging study Wozniak, Jeffrey R.
 2011
 21 Supplement 1 p. 89-96
8 p.
 artikel
43 WMS 2012 2011
 21 Supplement 1 p. 816-
1 p.
 artikel
44 WMS online application form 2011
 21 Supplement 1 p. II-
1 p.
 artikel
                             44 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland